Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

NCT04625972 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1131

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: AZD7442
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]